查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826802

2025年肝病诊断全球市场报告

Liver Disease Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肝病诊断市场规模强劲成长，从2024年的362.6亿美元增加至2025年的389.5亿美元，复合年增长率为7.4%。预测期内的增长可归因于急性和慢性肝病盛行率的上升、肝病盛行率的上升、酒精消费量的增加、人们对肝臟健康的认识的提高以及医疗基础设施的不断扩展。

预计未来几年肝病诊断市场将强劲成长，2029年将达到516.2亿美元，复合年增长率为7.3%。预测期内成长的主要驱动因素包括老年人口的成长、研发支出的增加、切片检查程序和疾病的增加以及远端医疗的普及。预测期内的主要趋势包括个人化医疗的兴起、诊断套件的技术进步、快速检测的进步、医疗保健的技术进步以及诊断方法的技术进步。

肝病诊断包括用于检测和评估各种肝病（包括肝硬化、肝炎、脂肪肝和肝癌）的医疗程序和检查。这些诊断程序通常包括：血液检查（用于测量肝臟酵素水平）、影像学检查（例如超音波或CT扫描），有时还包括切片检查（用于取出组织样本）。

肝病的主要诊断方法包括实验室检查、影像学检查、内视镜检查和切片检查。实验室检查透过分析血液和其他样本来确定肝臟状况。这些检查用于诊断非酒精性脂肪肝病、非酒精性脂肪性肝炎、纤维化、肝硬化和肝细胞癌等疾病。这些检查的最终使用者包括医院、实验室和其他医疗机构。

2025 年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗保健提供者正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品成本的上涨，其中许多产品的国内替代品有限。这些不断上涨的成本使医疗保健预算捉襟见肘，导致一些医疗机构推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，造成供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供肝病诊断市场统计数据，包括全球市场规模、区域份额、肝病诊断市场份额竞争对手、详细的肝病诊断细分市场、市场趋势和机会，以及您在肝病诊断行业取得成功所需的数据。本肝病诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年7.3%的成长预测比我们先前的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。关税上涨可能会增加美国实验室的负担，因为这会增加从中国和荷兰进口的专业肝功能检测试剂盒和FibroScan设备的成本，从而加剧诊断延误，并增加肝病检测的成本。互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响可能会产生更广泛的影响。

预计酒精消费量的上升将推动肝病诊断市场的成长。由于社会规范的改变、价格承受能力的提高、酒精的广泛供应以及压力和心理健康挑战的增加，酒精消费量正在增加。由于饮酒会影响肝臟健康，因此诊断工具对于早期发现脂肪肝、肝炎和肝硬化等肝损伤征兆至关重要。例如，根据英国国家医疗服务体系 (NHS) 2022 年 12 月的数据，酒精消费量随着年龄的增长而增加，62% 的 16 至 24 岁人群报告在过去 12 个月内饮酒，85% 的 55 至 74 岁人群饮酒。这一趋势正在推动肝病诊断市场的成长，因为人们对早期发现和监测肝臟健康的需求日益增长。

肝病诊断市场的公司正专注于开发创新的、非侵入性工具来评估肝臟健康状况。这些工具提供了准确有效的诊断方法，而无需切片检查等侵入性程序。例如，2024 年 9 月，印度诊断中心 City Imaging & Clinical 推出了 FibroScan，这是一种非侵入性诊断工具，旨在早期发现肝病，例如非酒精性脂肪肝病 (NAFLD) 和酒精性肝病 (ALD)。 FibroScan 使用弹性成像技术快速且准确地测量肝臟硬度和脂肪含量，为传统切片检查提供了一种非侵入性替代方案。该过程仅需 5 到 15 分钟；将探针放在肝臟上并发出声波以评估肝组织硬度，从而能够早期诊断纤维化和疤痕形成等疾病。

2024年8月，美国医疗检测公司Quest Diagnostics以10亿美元收购了LifeLabs。此次收购预计将显着增强Quest Diagnostics的营运能力，并拓展其在加拿大的医疗服务。总部位于加拿大的LifeLabs专注于肝病诊断，尤其擅长非酒精性脂肪性肝病（NAFLD）等疾病的诊断，此次收购将拓宽Quest在该领域的诊断服务。

肝病诊断市场由提供肝病诊断、影像检查、纤维化评估、病毒性肝炎筛检和酒精相关肝病评估等服务的提供者所获得的收益所构成。市场价值包括服务提供者销售的或包含在其服务产品中的相关产品的价值。肝病诊断市场还包括血液检测套组、诊断影像设备以及切片穿刺针和器械的销售。此市场的价值是指“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肝病诊断：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球肝病诊断市场：成长率分析
  • 全球肝病诊断市场表现：规模与成长，2019-2024
  • 全球肝病诊断市场预测：规模与成长，2024-2029年，2034年
  • 全球肝病诊断：总目标市场（TAM）

第六章 市场细分

  • 全球肝病诊断市场（依诊断技术）：2019-2024 年、2024-2029 年、2034 年表现与预测
  • 实验室检查
  • 影像学
  • 内视镜检查
  • 切片检查
  • 其他诊断技术
  • 全球肝病诊断市场：按疾病、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 非酒精性脂肪肝
  • 非酒精性脂肪性肝炎
  • 纤维化
  • 肝硬化
  • 肝细胞癌
  • 其他疾病
  • 全球肝病诊断市场（按最终用户、绩效和预测）2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 研究所
  • 其他最终用户
  • 全球肝病诊断市场：按临床测试类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 血液检查（肝功能检查、肝炎检查）
  • 酵素测试（ALT、AST、ALP）
  • 基因检测
  • 血清检测
  • 全球肝病诊断市场：依影像（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 超音波影像
  • 电脑断层扫描
  • MRI
  • 弹性成像（FibroScan）
  • 全球肝病诊断市场：内视镜细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 食道胃十二指肠镜检查（EGD）
  • 胶囊内视镜
  • 全球肝病诊断市场：依切片检查类型、表现及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 切片检查（针吸切片）
  • 细针穿刺切片检查
  • 腹腔镜切片检查
  • 全球肝病诊断市场：依其他诊断技术细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 分子影像
  • 生物标记检测
  • 纤维化评分系统

第七章 区域和国家分析

  • 全球肝病诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球肝病诊断市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 肝病诊断市场：竞争格局
  • 肝病诊断市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Echosens SA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • bioMerieux SA
  • Genentech Inc.
  • Perspectum Diagnostics Ltd.
  • Owlstone Medical Ltd.
  • Enterome SA
  • Atlentis Therapeutics AG
  • 89bio Inc.
  • Aligos Therapeutics Inc.
  • BioPredictive SAS
  • Cosara Diagnostics Pvt. Ltd.
  • Hepion Pharmaceuticals Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年肝病诊断市场：提供新机会的国家
  • 2029 年肝病诊断市场：细分市场将带来新机会
  • 2029年肝病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33792u

Liver disease diagnostics encompass the medical procedures and tests used to detect and evaluate a range of liver conditions, such as liver cirrhosis, hepatitis, fatty liver disease, and liver cancer. These diagnostic methods typically include blood tests to measure liver enzyme levels, imaging techniques such as ultrasound or CT scans, and occasionally biopsy procedures to collect tissue samples.

The primary diagnostic techniques for liver disease include laboratory tests, imaging, endoscopy, biopsy, and other methods. Laboratory tests involve analyzing blood and other samples to identify liver conditions. These tests are used to diagnose diseases such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, fibrosis, cirrhosis, hepatocellular carcinoma, and more. They are utilized by a variety of end users, including hospitals, laboratories, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The liver disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides liver disease diagnostics market statistics, including liver disease diagnostics industry global market size, regional shares, competitors with a liver disease diagnostics market share, detailed liver disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the liver disease diagnostics industry. This liver disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liver disease diagnostics market size has grown strongly in recent years. It will grow from $36.26 billion in 2024 to $38.95 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to the growing prevalence of both acute and chronic liver conditions, increasing prevalence of liver diseases, increasing consumption of alcohol, rising awareness towards liver health, and expanding healthcare infrastructure.

The liver disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $51.62 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to an increase in the geriatric population, rising research & development spending, an increasing number of biopsy procedures and diseases, and expanding telemedicine adoption. Major trends in the forecast period include the rise of personalized medicine, technological advancements in diagnostic kits, advancements in rapid tests, technological advancement in the healthcare sector, and technological advancements in diagnostic methods.

The forecast of 7.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. laboratories by driving up the cost of specialized liver function test panels and FibroScan equipment sourced from China and the Netherlands, exacerbating diagnostic delays and increasing hepatology workup expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in alcohol consumption is expected to drive the growth of the liver disease diagnostics market. Alcohol consumption has increased due to changing social norms, greater affordability, widespread availability, and rising stress or mental health challenges. As alcohol consumption impacts liver health, diagnostic tools are essential for detecting early signs of liver damage, such as fatty liver, hepatitis, or cirrhosis. For example, according to the National Health Service (NHS) in December 2022, alcohol consumption rose with age, with 62% of individuals aged 16 to 24 reporting consumption in the past 12 months, and 85% of individuals aged 55 to 74 engaging in alcohol consumption. This trend is contributing to the growth of the liver disease diagnostics market, as there is a greater need for early detection and monitoring of liver health.

Companies in the liver disease diagnostics market are focusing on the development of innovative, non-invasive tools to assess liver conditions. These tools provide accurate and efficient diagnostic methods without the need for invasive procedures such as biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool aimed at the early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). FibroScan uses elastography technology to measure liver stiffness and fat content quickly and accurately, offering a non-invasive alternative to traditional biopsies. The procedure takes only 5 to 15 minutes and involves placing a probe over the liver, which emits sound waves to assess liver tissue stiffness, enabling early diagnosis of conditions such as fibrosis or scarring.

In August 2024, Quest Diagnostics, a US-based medical laboratory company, acquired LifeLabs for $1 billion. This acquisition is expected to significantly enhance Quest Diagnostics' operational capabilities and expand its healthcare services in Canada. LifeLabs, a Canada-based laboratory company, specializes in liver disease diagnostics, particularly focusing on conditions such as non-alcoholic fatty liver disease (NAFLD), and the acquisition will help broaden Quest's diagnostic offerings in this area.

Major players in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMerieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, and Aiforia Technologies Plc.

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in liver disease diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the liver disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The liver disease diagnostics market consists of revenues earned by entities by providing services such as liver disease diagnostics, imaging studies, fibrosis assessment, viral hepatitis screening, and alcohol-related liver disease evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver disease diagnostics market also includes sales of blood test kits, imaging devices, and biopsy needles and instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liver Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liver disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liver disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The liver disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques
  • 2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases
  • 3) By End Users: Hospitals; Laboratories; Other End Users
  • Subsegments:
  • 1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests
  • 2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)
  • 3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy
  • 4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy
  • 5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Fujifilm Holdings Corporation; Echosens SA; Boston Scientific Corporation; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Siemens Healthineers AG; bioMerieux SA; Genentech Inc.; Perspectum Diagnostics Ltd.; Owlstone Medical Ltd.; Enterome SA; Atlentis Therapeutics AG; 89bio Inc.; Aligos Therapeutics Inc.; BioPredictive SAS; Cosara Diagnostics Pvt. Ltd.; Hepion Pharmaceuticals Inc.; HEPQuant LLC; Aiforia Technologies Plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liver Disease Diagnostics Market Characteristics

3. Liver Disease Diagnostics Market Trends And Strategies

4. Liver Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Liver Disease Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Liver Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Liver Disease Diagnostics Market Growth Rate Analysis
  • 5.4. Global Liver Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Liver Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Liver Disease Diagnostics Total Addressable Market (TAM)

6. Liver Disease Diagnostics Market Segmentation

  • 6.1. Global Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Other Diagnosis Techniques
  • 6.2. Global Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Alcoholic Fatty Liver Disease
  • Non-Alcoholic Steatohepatitis
  • Fibrosis
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Other Diseases
  • 6.3. Global Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Laboratories
  • Other End Users
  • 6.4. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests (Liver Function Tests, Hepatitis Panel)
  • Enzyme Tests (ALT, AST, ALP)
  • Genetic Testing
  • Serological Tests
  • 6.5. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound Imaging
  • CT Scans
  • MRI
  • Elastography (FibroScan)
  • 6.6. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Esophagogastroduodenoscopy (EGD)
  • Capsule Endoscopy
  • 6.7. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Biopsy (Needle Biopsy)
  • Fine Needle Aspiration Biopsy
  • Laparoscopic Biopsy
  • 6.8. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Other Diagnosis Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Imaging
  • Biomarker Testing
  • Fibrosis Scoring Systems

7. Liver Disease Diagnostics Market Regional And Country Analysis

  • 7.1. Global Liver Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Liver Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Disease Diagnostics Market

  • 8.1. Asia-Pacific Liver Disease Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Disease Diagnostics Market

  • 9.1. China Liver Disease Diagnostics Market Overview
  • 9.2. China Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Disease Diagnostics Market

  • 10.1. India Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Disease Diagnostics Market

  • 11.1. Japan Liver Disease Diagnostics Market Overview
  • 11.2. Japan Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Disease Diagnostics Market

  • 12.1. Australia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Disease Diagnostics Market

  • 13.1. Indonesia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Disease Diagnostics Market

  • 14.1. South Korea Liver Disease Diagnostics Market Overview
  • 14.2. South Korea Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Disease Diagnostics Market

  • 15.1. Western Europe Liver Disease Diagnostics Market Overview
  • 15.2. Western Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Disease Diagnostics Market

  • 16.1. UK Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Disease Diagnostics Market

  • 17.1. Germany Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Disease Diagnostics Market

  • 18.1. France Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Disease Diagnostics Market

  • 19.1. Italy Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Disease Diagnostics Market

  • 20.1. Spain Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Disease Diagnostics Market

  • 21.1. Eastern Europe Liver Disease Diagnostics Market Overview
  • 21.2. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Disease Diagnostics Market

  • 22.1. Russia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Disease Diagnostics Market

  • 23.1. North America Liver Disease Diagnostics Market Overview
  • 23.2. North America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Disease Diagnostics Market

  • 24.1. USA Liver Disease Diagnostics Market Overview
  • 24.2. USA Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Disease Diagnostics Market

  • 25.1. Canada Liver Disease Diagnostics Market Overview
  • 25.2. Canada Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Disease Diagnostics Market

  • 26.1. South America Liver Disease Diagnostics Market Overview
  • 26.2. South America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Disease Diagnostics Market

  • 27.1. Brazil Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Disease Diagnostics Market

  • 28.1. Middle East Liver Disease Diagnostics Market Overview
  • 28.2. Middle East Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Disease Diagnostics Market

  • 29.1. Africa Liver Disease Diagnostics Market Overview
  • 29.2. Africa Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Disease Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Liver Disease Diagnostics Market Competitive Landscape
  • 30.2. Liver Disease Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Echosens SA Overview, Products and Services, Strategy and Financial Analysis

31. Liver Disease Diagnostics Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Laboratory Corporation of America Holdings
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Siemens Healthineers AG
  • 31.5. bioMerieux SA
  • 31.6. Genentech Inc.
  • 31.7. Perspectum Diagnostics Ltd.
  • 31.8. Owlstone Medical Ltd.
  • 31.9. Enterome SA
  • 31.10. Atlentis Therapeutics AG
  • 31.11. 89bio Inc.
  • 31.12. Aligos Therapeutics Inc.
  • 31.13. BioPredictive SAS
  • 31.14. Cosara Diagnostics Pvt. Ltd.
  • 31.15. Hepion Pharmaceuticals Inc.

32. Global Liver Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Disease Diagnostics Market

34. Recent Developments In The Liver Disease Diagnostics Market

35. Liver Disease Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Liver Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Liver Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Liver Disease Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer